ASCITES is a problem frequently encountered and often unsatisfactorily treated. An adjunct in the therapy of ascites has been tried in a limited number of cases and has seemed sufficiently helpful to ...

THE problem of the accumulation of fluid in the peritoneal cavity in association with cirrhosis of the liver has for many years presented a challenge to the surgeon, since it has always been tempting ...

Ascites Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for ...

New York, USA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Ascites Market to Observe Stunning Growth During the Study Period (2019–2032) | DelveInsight DelveInsight’s Ascites Market Insights report includes a ...

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Ascites Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been added to ...

Rising prevalence of cirrhosis is a major factor boosting the growth of the global malignant ascites market. According to a study published in the World Journal of Gastroenterology in 2011, over 50% ...

Do you know what is ascites? It is the build up of fluid in the abdomen. This fluid buildup makes your abdomen swollen and it mostly occurs over a few weeks. The condition ascites is very ...

Challenges in developing drugs for pancreatic ductal adenocarcinoma (PDAC) include obtaining metastatic cancer tissue for research and validating biomarkers predicative for personalised therapeutic ...

Fatty liver disease is sometimes called “silent liver disease” because of the few signs it shows until it has progressed. According to the NHS, one in three may be living with the early signs of fatty ...

The Ascites may be due to cancer like ovarian malignancy. Cirrhosis of liver is the most common cause and the underlying liver disease is to be addressed first. The patient has to be counselled to ...

"Ascites in decompensated cirrhosis is a poor prognostic indicator, with a 50% 2-year survival, worsening significantly to 20% to 50% at 1 year when the ascites becomes refractory to medical therapy." ...